Phase 1 Oncolytic Virus Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1
Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma
Adverse Drug EventDiffuse Intrinsic Pontine GliomaOncolytic Virus
Capital Medical University18 enrolled1 locationNCT05717712
Recruiting
Phase 1
Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma
Adverse Drug EventDiffuse Intrinsic Pontine GliomaOncolytic Virus
Capital Medical University18 enrolled1 locationNCT05717699